- Home
- Suprava TZ 562.5 mg Injection 1's
Suprava TZ 562.5 mg Injection 1's Substitute
Suprava TZ 562.5 mg Injection 1's Substitute
Maczone XP 500 Injection 5 ml
by Others
₹28.26per tabletAccutaz HS 500 mg/62.5 mg Injection 1's
by Others
₹141.30per tabletCEFOPROX XP 500MG INJECTION
by Others
₹146.70per tabletMontaz 500 mg Injection 1's
by Others
₹135.00per tabletSWICH XP 500MG INJECTION
by Others
₹117.00per tabletTAZOCEF 500MG INJECTION
by Others
₹66.60per tablet
Verified Ingredients and Effects
Composition:
CEFTRIAXONE-500MG + TAZOBACTAM-62.5MG
Uses:
Suprava TZ 562.5 mg Injection 1's is used in the treatment of bacterial infections. The detailed uses of Suprava TZ 562.5 mg Injection 1's are as follows:<br/>•Treatment of Bacterial Infections: Suprava TZ 562.5 mg Injection 1's is commonly prescribed to manage bacterial infections, including those targeting the respiratory tract, urinary tract, and skin, ensuring effective treatment.<br/>•Post-Surgical Infection Prevention: Suprava TZ 562.5 mg Injection 1's may be administered to reduce the risk of infections in patients undergoing surgery, particularly during high-risk procedures.<br/>•Management of Sepsis: Suprava TZ 562.5 mg Injection 1's is used as part of the treatment regimen for sepsis, a life-threatening condition caused by infection.<br/>•Pneumonia Treatment: Suprava TZ 562.5 mg Injection 1's is effective in treating pneumonia, especially when caused by bacterial pathogens sensitive to its active components.<br/>•Typhoid Fever Management: Suprava TZ 562.5 mg Injection 1's may be prescribed for typhoid fever, particularly in situations where oral medications are unsuitable or ineffective.<br/>
Medicinal Benefits:
Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor) used to treat several bacterial infections. Ceftriaxone is a broad-spectrum antibiotic that acts against both aerobic (grow in the presence of oxygen) and anaerobic (grow in the absence of oxygen) gram-negative and gram-positive bacteria. It interferes with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
FAQs
Suprava TZ 562.5 mg Injection 1's is used to treat bacterial infections of the urinary tract, blood, bones and joints, heart, brain, chest, ears, skin, or soft tissues.
Suprava TZ 562.5 mg Injection 1's contains Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic that works by interfering with the formation of the bacterial cell wall (a protective covering) that is necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
Suprava TZ 562.5 mg Injection 1's may interfere with urine test (for sugar) and Coomb’s test (blood test) giving false-positive results. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking Suprava TZ 562.5 mg Injection 1's.
You are not recommended to take Suprava TZ 562.5 mg Injection 1's with streptomycin as co-administration of these two medicines may increase the risk of kidney damage. However, please consult your doctor before taking Suprava TZ 562.5 mg Injection 1's with other medicines to adjust the dose appropriately.
Suprava TZ 562.5 mg Injection 1's may cause diarrhoea as a common side effect. However, if the condition persists, worsens or notices blood or mucus in stools, avoid taking Suprava TZ 562.5 mg Injection 1's and consult a doctor immediately.
Suprava TZ 562.5 mg Injection 1's is not used to treat viral infections. Suprava TZ 562.5 mg Injection 1's is an antibiotic which is used to treat only bacterial infections.
Suprava TZ 562.5 mg Injection 1's should be used with caution in patients with kidney problems as it may increase the risk of adverse effects. Therefore, inform your doctor if you have any kidney problems before taking Suprava TZ 562.5 mg Injection 1's so that the dose may be adjusted accordingly.
Generally, Suprava TZ 562.5 mg Injection 1's starts working soon after taking it, as it is injected directly into the blood stream. However to kill all the harmful bacteria and make you feel better, it may take some days. So, complete the full course of treatment as prescribed by your doctor.
Inform your doctor if you don't get better after finishing the full course of treatment as prescribed by your doctor. Also, inform if your symptoms are getting worse while using Suprava TZ 562.5 mg Injection 1's.
The common side effects of Suprava TZ 562.5 mg Injection 1's are diarrhoea, rash, raised white blood cells, raised platelets, nausea, vomiting, stomach upset, blood clots, dizziness, headache, a lump where the medicine was injected and sweating. If any of these side effects persist or worsen, please consult your doctor.
